Alpha-msh related compounds and methods of use
CA 2415938 A1 · Owner: Aziz, Nazneen · Inventors: Aziz, Nazneen; Yin, Peng; Hedley, Mary Lynne
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The invention provides polypeptides containing .alpha.-MSH that can be used to treat diseases characterized by inflammation and/or autoimmunity. Also included in the invention are .alpha.-MSH analogs and nucleic acids encoding polypeptides containing .alpha.-MSH and .alpha.-MSH analogs optionally linked to heterologous sequences. Also included in the invention are methods of delivering .alpha.-MSH containing peptides .alpha.-MSH analogs, an DNA , encoding .alpha.-MSH and .alpha.-MSH analogs.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed July 16, 2001. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended July 16, 2021.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by July 16, 2023.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.